Mrs Marybeth Walker Floyd, FNP | |
519 Enon Springs Rd E, Smyrna, TN 37167-4446 | |
(615) 223-6200 | |
Not Available |
Full Name | Mrs Marybeth Walker Floyd |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 17 Years |
Location | 519 Enon Springs Rd E, Smyrna, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215194691 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 13395 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Precision Pain Care Pllc | 4082611512 | 3 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Entity Name | Precision Pain Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013930494 PECOS PAC ID: 4082611512 Enrollment ID: O20061026000115 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Entity Name | Memphis Urgent Care #2 Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164840609 PECOS PAC ID: 0648407023 Enrollment ID: O20131210000737 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Entity Name | Memphis Urgent Care #1, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073935003 PECOS PAC ID: 9335468206 Enrollment ID: O20150428001395 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Entity Name | Carespot Of Memphis, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518405034 PECOS PAC ID: 4587940903 Enrollment ID: O20170418002889 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Marybeth Walker Floyd, FNP 521 Enon Springs Rd E, Smyrna, TN 37167-4446 Ph: (615) 223-6200 | Mrs Marybeth Walker Floyd, FNP 519 Enon Springs Rd E, Smyrna, TN 37167-4446 Ph: (615) 223-6200 |
News Archive
Fuisz Pharma today announced the issuance of U.S. Patent 7,824,612 Bodily fluid analyzer, and system including same and method for programming same.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
The National Institutes of Health (NIH) has designated the University of Alabama at Birmingham (UAB) one of only six Diabetes Research and Training Centers (DRTC) in the country, putting UAB at the forefront in the development of new methods to treat, prevent and, ultimately, cure diabetes and its complications.
More than half of physicians believe that religion and spirituality have a significant influence on patients' health, according to a report in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 5 days ago
Krista Delaine Gessler, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13181 Old Nashville Hwy, Suite 150, Smyrna, TN 37167 Phone: 615-355-5105 Fax: 615-355-5195 | |
Caleb Fresh, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 515 Stonecrest Pkwy Ste 230, Smyrna, TN 37167 Phone: 152-239-9356 | |
Norma Jean Smith Richcreek, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 301 Wolverine Trl Ste 201, Smyrna, TN 37167 Phone: 615-768-5511 | |
Mrs. Tehri Kellie Roberts, MSN FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Stonecrest Blvd Ste 110, Smyrna, TN 37167 Phone: 615-223-6606 Fax: 615-223-6629 | |
Ms. Michele Renee Lee, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 739 President Pl, Smyrna, TN 37167 Phone: 615-459-3244 | |
Lisa C Wood, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1335 Rock Springs Rd, Suite 100, Smyrna, TN 37167 Phone: 615-459-5252 Fax: 615-459-5232 | |
Amanda Nicole Mason, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Stonecrest Blvd Ste 230, Smyrna, TN 37167 Phone: 615-730-8626 Fax: 615-840-6169 |